Short-term healing response after implantation of the thin-strut, fast-releasing sirolimus-eluting biodegradable polymer-coated Alex Plus stent: optical coherence tomography study

Código QR

Short-term healing response after implantation of the thin-strut, fast-releasing sirolimus-eluting biodegradable polymer-coated Alex Plus stent: optical coherence tomography study

Guardado en:

Detalles Bibliográficos
Autores principales:	Magdalena Dobrolińska, Paweł Gąsior, Tomasz Roleder, Magda Roleder-Dylewska, Grzegorz Smolka, Andrzej Ochała, Elvin Kedhi, Wojciech Wojakowski
Formato:	article
Lenguaje:	EN
Publicado:	Termedia Publishing House 2020
Materias:	Medicine R
Acceso en línea:	https://doaj.org/article/2b2a340fd82a4201a45caa82b17355ac
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Early scaffold strut coverage in ultra-high molecular weight amorphous PLLA sirolimus-eluting bioresorbable scaffolds: impact of strut thickness assessed in normal porcine coronary arteries
por: Paweł Gąsior, et al.
Publicado: (2020)

Long-term effectiveness and safety of sirolimus drug-eluting stents
por: Bikkina M, et al.
Publicado: (2011)

Biodegradable Cable-Tie Rapamycin-eluting Stents
por: Cheng-Hung Lee, et al.
Publicado: (2017)

Head-to-head comparison of sirolimus-eluting stents versus paclitaxel-eluting stents in patients undergoing percutaneous coronary intervention: a meta-analysis of 76 studies.
por: Xinlin Zhang, et al.
Publicado: (2014)

Procedural and short-term clinical outcomes post-PCI using newer generation ultrathin sirolimus-eluting stent with biodegradable polymer coating in real-world population
por: Pravin K. Goel, et al.
Publicado: (2021)

Clinical outcomes of ultrathin biodegradable polymer-coated sirolimus-eluting stents in an all-comer population: One-year results from the T-FLEX registry including high-risk subgroups
por: Ramesh Babu Pothineni, et al.
Publicado: (2021)

Real-world registry of the durable Angiolite fluoroacrylate polymer-based sirolimus-eluting stent: the EPIC02 – RANGO study
por: Armando Pérez de Prado, et al.
Publicado: (2021)

Strut Linker Geometry Improving Mechanical Behaviorof Coronary Stent
por: Rachmat Sriwijaya, et al.
Publicado: (2020)

Long term safety and efficacy of the Yukon Choice Flex sirolimus-eluting coronary stent-a real-world data from India
por: Basant Kumar, et al.
Publicado: (2021)

Ultrathin (60 μm), ultralong (≥40 mm) sirolimus-eluting stent: study of clinical and safety profiles among real-world patients
por: Santosh Kumar Sinha, et al.
Publicado: (2021)

Everolimus-eluting coronary stents
por: Alejandro Saez, et al.
Publicado: (2010)

Biosafety and efficacy evaluation of a biodegradable magnesium-based drug-eluting stent in porcine coronary artery
por: Jinzhou Zhu, et al.
Publicado: (2021)

Comparison of the everolimus-eluting bioresorbable vascular scaffold versus the everolimus-eluting metallic stent in real-world patients with ST-segment elevation myocardial infarction
por: Piotr Desperak, et al.
Publicado: (2020)

Biodegradable polymer Biolimus-eluting stent (Nobori®) for the treatment of coronary artery lesions: review of concept and clinical results
por: Schurtz G, et al.
Publicado: (2014)

Clinical outcomes in 2481 unselected real-world patients treated with a polymer-free sirolimus-eluting stent: 3 years results from the NANO multicenter Registry
por: Yi Dai, et al.
Publicado: (2021)

Drug-eluting stents with biodegradable polymer for the treatment of patients with diabetes mellitus: clinical outcome at 2 years in a large population of patients
por: Wiemer M, et al.
Publicado: (2015)

New drug-eluting stents: technological refinement continues
por: Javier Suárez de Lezo, et al.
Publicado: (2021)

Everolimus-eluting stents: update on current clinical studies
por: Allocco DJ, et al.
Publicado: (2011)

Prophylactic paclitaxel-eluting stent placement does not improve covered femoropopliteal stent patency
por: Rory Marples, MBBS, et al.
Publicado: (2022)

Biodegradable andrographolide-eluting nanofibrous membranes for the treatment of cervical cancer
por: Chen YP, et al.
Publicado: (2019)

Promoting vascular healing using nanofibrous ticagrelor-eluting stents
por: Lee CH, et al.
Publicado: (2018)

Saphenous Vein Graft Aneurysm after Drug-Eluting Stent Implantation: Treatment by Covered Stent
por: Kyriacos Papadopoulos, et al.
Publicado: (2021)

Advances in drug eluting stents &ndash; focus on the Endeavor&reg; zotarolimus stent
por: Jonathan Bridges, et al.
Publicado: (2008)

A Case of Stent Fracture and Very Late Stent Thrombosis 15 Months after Drug-Eluting Stent Implantation
por: A Ghaemian,, et al.
Publicado: (2009)

Preclinical evaluation of sorafenib-eluting stent for suppression of human cholangiocarcinoma cells
por: Kim DH, et al.
Publicado: (2013)

Next generation drug-eluting stents: focus on bioabsorbable platforms and polymers
por: Brendan Doyle, et al.
Publicado: (2009)

Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery – focus on the paclitaxel eluting stent
por: Litsky J, et al.
Publicado: (2014)

Comparison between a Bare–Metal Stents and Drug Eluting Stents in patients undergoing Percutaneous Coronary Intervention.
por: Khaled Alsayed
Publicado: (2020)

Comparison of Drug-Coated Balloon Angioplasty vs. Drug-Eluting Stent Implantation for Drug-Eluting Stent Restenosis in the Routine Clinical Practice: A Meta-Analysis of Randomized Controlled Trials
por: Yong Zhu, et al.
Publicado: (2021)

Everolimus-eluting stent platforms in percutaneous coronary intervention: comparative effectiveness and outcomes
por: Panoulas VF, et al.
Publicado: (2015)

Impact of stent edge dissection detected by optical coherence tomography after current-generation drug-eluting stent implantation.
por: Hiroyuki Jinnouchi, et al.
Publicado: (2021)

Impact of stent edge dissection detected by optical coherence tomography after current-generation drug-eluting stent implantation
por: Hiroyuki Jinnouchi, et al.
Publicado: (2021)

A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease
por: Bennett J, et al.
Publicado: (2013)

The everolimus-eluting Xience stent in small vessel disease: bench, clinical, and pathology view
por: Sanchez OD, et al.
Publicado: (2014)

Impact of hospital and sociodemographic factors on utilization of drug-eluting stents in 2011-2012 Medicare cohort
por: Tushar A Tuliani, et al.
Publicado: (2017)

Drug diffusion and biological responses of arteries using a drug-eluting stent with nonuniform coating
por: Saito N, et al.
Publicado: (2016)

Coronary Endothelium‐Dependent Vasomotor Function After Drug‐Eluting Stent and Bioresorbable Scaffold Implantation
por: Josep Gomez‐Lara, et al.
Publicado: (2021)

Application of galangin, an active component of Alpinia officinarum Hance (Zingiberaceae), for use in drug-eluting stents
por: Jung-Jin Lee, et al.
Publicado: (2017)

Safety and Efficacy of Rapamycin-Eluting Vertebral Stents in Patients With Symptomatic Extracranial Vertebral Artery Stenosis
por: Gaoting Ma, et al.
Publicado: (2021)

Extended pain relief achieved by analgesic-eluting biodegradable nanofibers in the Nuss procedure: in vitro and in vivo studies
por: Liu K, et al.
Publicado: (2018)